Search results for "Keeping tabs"
Spotlight on pioglitazone
Evidence on possible risks of pioglitazone, including bladder cancer, prostate cancer, and fractures, made the news in the past month.
https://diabetes.acponline.org/archives/2017/01/13/9.htm
13 Jan 2017
Spotlight on older diabetes patients
Recent studies of older patients with diabetes described the effectiveness of a lifestyle intervention, low use of continuous glucose monitoring, and high risk of falls with hypoglycemia.
https://diabetes.acponline.org/archives/2022/08/12/5.htm
12 Aug 2022
Spotlight on undertreatment of risks from diabetes
Studies published in the past month looked at statin prescriptions for patients with diabetes and osteoporotic fracture risk in women with diabetes.
https://diabetes.acponline.org/archives/2016/09/16/9.htm
16 Sep 2016
Spotlight on activity
The American Diabetes Association (ADA) issued a new position statement on physical activity and exercise, and a recent study offered some additional advice on the topic.
https://diabetes.acponline.org/archives/2016/11/11/9.htm
11 Nov 2016
Spotlight on the gut microbiome
A Finnish study found that certain gut bacteria were more common in people who later developed type 2 diabetes, while an Israeli study identified a distinct microbial signature in adults with type 1 diabetes compared with healthy controls.
https://diabetes.acponline.org/archives/2022/02/11/5.htm
11 Feb 2022
Spotlight on telehealth for diabetes management
Two recent studies analyzed telehealth interventions to improve glycemic control among patients with type 2 diabetes and high HbA1c levels.
https://diabetes.acponline.org/archives/2016/08/12/9.htm
12 Aug 2016
Spotlight on body weight and diabetes complications
A systematic review found that weight gain was associated with increased cardiovascular risk in type 2 diabetes patients but that the effects of intentional weight loss were unclear, while another analysis found that higher body mass index was mostly not associated with cancer mortality.
https://diabetes.acponline.org/archives/2021/12/10/5.htm
10 Dec 2021
Spotlight on efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
https://diabetes.acponline.org/archives/2022/05/13/5.htm
13 May 2022
Spotlight on cardiovascular risk in type 2 diabetes
The American Heart Association released a scientific statement on managing cardiovascular (CV) risk factors, while recent research focused on CV mortality in patients with diabetes and nonalcoholic fatty liver disease and CV outcomes in high-risk patients who take sodium-glucose cotransporter-2 inhibitors.
https://diabetes.acponline.org/archives/2022/01/14/5.htm
14 Jan 2022
Spotlight on renal side effects
Renal side effects of diabetes drugs were in the news in the past month, with one industry-funded study finding an association between empagliflozin and slower progression of kidney disease and the FDA strengthening an existing warning on risk of acute kidney injury with canagliflozin and dapagliflozin.
https://diabetes.acponline.org/archives/2016/07/15/8.htm
15 Jul 2016